$GWPH News

Last published 2y ago

2y agoIDYA GWPH ATLNIDEAYA Biosciences Appoints Douglas B. Snyder as Senior Vice President, General CounselPR NewswireIDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics,...
5y agoGWPHEvaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis - NCT04984278ClinicalTrials.govChange in Lower Limb Muscle Tone-6 (LLMT-6) from Day 1 predose to Day 21 (Treatment Period 1) and from Day 31 predose to Day 51 (Treatment Period 2), Change in LLMT-4 from Day 1 predose to Day 21 and from Day 31 predose to Day 51, Number of participants with treatment-emergent adverse events, (and 7 more...)
5y agoGWPH JAZZ SEEL TRYPFNatural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True OpportunitiesPR NewswireNEW YORK, May 20, 2021 /PRNewswire/ -- Before government legislation brought the world of psychedelic drug compounds to a halt, promising research was being done in the space. As researchers and scientists took closer looks at substances such as psilocy
5y agoCGC GWPH OILFF SNDL+1CBD Oil Extract Market Share Projected To Reach $25.57 Billion by 2027PR NewswirePALM BEACH, Fla., May 6, 2021 /PRNewswire/ -- The CBD Oil extract market is growing but what exactly is making it grow? Recent reports indicate that it is the increasing preferences of oil and tinctures extracted from cannabis which is primarily drivin
5y agoGWPH JAZZJazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plcPR NewswireDUBLIN, May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (NASDAQ:JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (NASDAQ:GWPH) ("GW"), a leader in the science, development and commercialization of cannabinoid-based pres
5y agoCGC GWPH MEDIF OILFF+1Number Of Cannabis Patents Granted In Europe & UK Growing At A Quick PacePR NewswirePALM BEACH, Fla., April 29, 2021 /PRNewswire/ -- The worldwide explosion of the recreational and medical cannabis markets, and submarkets, appears that it will continue for years to come. New industries have been born, new mega-companies are growing and
5y agoGWPHGW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen's Award for Enterprise in InnovationGlobeNewswireLONDON, April 29, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ:GWPH) ("GW", "the Company" or "the Group"), a world leader in discovering, developing and commercialising regulatory approved cannabis-based medicines, announces that it has rece
5y agoGWPH JAZZGW Pharmaceuticals Shareholders Approve Acquisition by Jazz PharmaceuticalsGlobeNewswireLONDON and DUBLIN, April 23, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ:GWPH) (GW) and Jazz Pharmaceuticals plc (NASDAQ:JAZZ) (Jazz) today announced that GW's shareholders voted to approve the acquisition of GW by a subsidiary of Jazz (or
5y agoGWPHGW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complexGlobeNewswire– Tuberous sclerosis complex (TSC) represents a third indication for GW's cannabidiol in Europe – – TSC causes epilepsy in up to 85% of patients, and up to 60% of those patients do not respond to standard anti-epileptic medicines1,2,3 – LON
5y agoGWPH OGI CGC BTIImproving Quality of THC-Based Medications Proving to be Lucrative Path for Cannabis CompaniesPR NewswirePALM BEACH, Fla, April 15, 2021 /PRNewswire/ – 2020 was a prosperous year for medical marijuana. In fact, North America medical marijuana market size ...
5y agoGWPHGW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) Annual MeetingGlobeNewswireEPIDOLEX encore presentations highlight long-term safety and efficacy data in patients with tuberous sclerosis complex (TSC) and other treatment-resistant epilepsies Nabiximols data show efficacy and...
5y agoTLRY GWPH JAZZ JEF+3Greenlane and KushCo to Merge as Legal Cannabis Demand BoomsBloombergGreenlane Holdings Inc. and KushCo Holdings Inc., providers of cannabis industry packaging, accessories and services, are merging in an all-stock transaction that coincides with a push to extend legalization in the U.S.
5y agoCMPS GWPH ITCI PFENew Approaches to Mental Health are Changing the Healthcare SpacePR NewswireThe mental health treatment space is heading into a period of incredible innovation. New therapies and unconventional pharmaceuticals are receiving...
5y agoGWPHGW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use as treatment of seizures associated with Tuberous Sclerosis ComplexGlobeNewswireLONDON, Feb. 26, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), a world leader in discovering, developing and delivering regulatory approved...
5y agoGWPHGW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use as treatment of seizures associated with Tuberous Sclerosis ComplexGlobeNewswireLONDON, Feb. 26, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), a world leader in discovering, developing and delivering regulatory approved...
5y agoGWPH JAZZGW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2020 Financial Results and Operational ProgressGlobeNewswire– Total revenue of $148.2 million for the fourth quarter and $527.2 million for the full year – – Total Epidiolex® net product sales of $144.1 million for the fourth quarter and $510.5 million for...
5y agoGWPH JAZZ WBA ABC+2Quidel Weighing Deal With $12 Billion Testing Firm QiagenBloombergQuidel Corp., the U.S. diagnostics firm, is weighing a combination with Qiagen NV in another sign of ongoing appetite for dealmaking in the medical equipment industry, people with knowledge of the matter said.
5y agoFST GWPH HOL VIEMoore Kuehn Encourages FST, GWPH, HOL, and VIE Investors to Contact Law FirmPR NewswireMoore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
5y agoJAZZ GWPHJazz Pharmaceuticals to buy GW Pharmaceuticals in a $7.2 billion dealCNBCJazz Pharmaceuticals said on Wednesday it would buy GW Pharmaceuticals in a cash-and-stock deal worth $7.2 billion.
5y agoJAZZ GWPHJazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma LeaderPR NewswireJazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies have entered into a definitive...
5y agoGWPHGW Pharmaceuticals plc. (GWPH) CEO Justin Gover on 39th Annual JPMorgan Virtual Healthcare Conference - (Transcript)Earnings Call Transcripts
5y agoGWPHGW Pharmaceuticals Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program MilestonesGlobeNewswire- Total preliminary net product sales of approximately $148 million for the fourth quarter and approximately $526 million for the full year -- Total Epidiolex® preliminary net product sales of...
5y agoGWPH TLRY ACBGlobal Recognition Helps Propel the Expansion of the CBD and Cannabis MarketPR NewswireThe cannabis industry has had some major accomplishments in recent years. 16 states have now fully legalized the use of cannabis products for both...
5y agoGWPHCORRECTING and REPLACING - GW Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireLONDON and CARLSBAD, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- In a release issued earlier today by GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group) under the same headline,...
5y agoGWPHGW Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireLONDON and CARLSBAD, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and...
5y agoGWPHJAMA Neurology Publishes Phase 3 Study of EPIDIOLEX® (cannabidiol) Oral Solution in Patients with Seizures Associated with Tuberous Sclerosis ComplexGlobeNewswireCARLSBAD, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of...
5y agoGWPHTrial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients With Multiple Sclerosis - NCT04657666ClinicalTrials.govChange from Baseline in Lower Limb Muscle Tone-6 (LLMT-6) to Day 21 and Day 51, Change from Baseline in Lower Limb Muscle Tone-4 (LLMT-4) to Day 21 and Day 51, Number of Participants with Treatment-Emergent Adverse Events (TEAEs), (and 9 more...)
5y agoGWPHGW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy & Pain – Specialty CNS Therapeutics ConferenceGlobeNewswireLONDON and CARLSBAD, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization...
5y agoSTZ TAP MO GWPHHow An Ancient Medicine Is Taking On The $16 Trillion Pharmaceutical IndustryPR Newswire2021 could be a big year for this soon-to-be $16-trillion biotech opportunity. More importantly, it could be a big year for companies pioneering a...
5y agoGWPHGreenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at the American Epilepsy Society Annual MeetingGlobeNewswire- Meeting Highlights Include New Long-Term Data in Tuberous Sclerosis Complex - CARLSBAD, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in...
5y agoGWPHGW Pharmaceuticals to Present at the Evercore ISI 2020 Healthcare ConferenceGlobeNewswireLONDON and CARLSBAD, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization...
5y agoGWPHGW Pharmaceuticals plc (GWPH) CEO Justin Grover presents at Stifel Virtual Healthcare Conference (Transcript)Earnings Call Transcripts
6y agoGWPHGreenwich Biosciences to Present Analysis of Three Clinical Studies of Nabiximols for People with Multiple Sclerosis Related Spasticity at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual AssemblyGlobeNewswire- Results from analysis of three Phase 3 clinical studies showed statistically significant improvement in spasticity in people with multiple sclerosis - Treatment with nabiximols seen in this...
6y agoGWPHGW Pharmaceuticals to Present at the Stifel 2020 Virtual Healthcare ConferenceGlobeNewswireLONDON and CARLSBAD, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization...
6y agoGWPHGW Pharmaceuticals plc's (GWPH) CEO Justin Gover on Q3 2020 Results - Earnings Call TranscriptEarnings Call Transcripts
6y agoGWPHGW Pharmaceuticals plc Reports Third Quarter 2020 Financial Results and Operational ProgressGlobeNewswire- Total revenue increased 51 percent to $137.1 million – - Epidiolex for seizures associated with TSC launched in the U.S. -- Nabiximols Phase 3 program in MS spasticity now recruiting -- Conference...
6y agoGWPHGW Pharmaceuticals Initiates Pivotal Phase 3 Study of Nabiximols for Multiple Sclerosis-Associated SpasticityGlobeNewswireCARLSBAD, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of...
6y agoGWPHGW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Third Quarter Ending September 30th, 2020 and Host Conference Call on November 3rd, 2020GlobeNewswireLONDON and CARLSBAD, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and...
6y agoGWPHGreenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy CommunityGlobeNewswire-- Technology provides a new way for the community to communicate and connect -- -- Launching in collaboration with patient advocacy organizations, this web-based, image-recognition technology...
6y agoGWPHStudy of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder - NCT04592159ClinicalTrials.govChange from Baseline in Clinician Administered Post-Traumatic Stress Disorder (PTSD) Scale (Clinician Administered PTSD Scale [CAPS-5]) Score over 8 Weeks, Number of Participants Exhibiting Improvements Rated as Much or Very Much Improved on the Clinical Global Impressions Improvement (CGI-I) Scale at the End of Treatment (over 8 Weeks), Change from Baseline in the Self-Reported PTSD Checklist for ...
6y agoZIXI GWPH SHOP-CA SNOW+2Cramer's lightning round: TJX Companies is 'not what people want right now'CNBC"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
6y agoGWPH TLRY ZYNE ACBMedical Cannabis Legalization Helps Destigmatize Related ProductsPR NewswirePresently, the medical cannabis sector accounts for the majority of the market share, and progress is slowly being made in removing the stigmas...
6y agoHEXO ZYNE GWPHLegalization Efforts Continue to Drive the Cannabis Market GrowthPR NewswireThe legalization of cannabis in several countries is one of the key factors driving the market's growth. In addition, the use of cannabis for medical ...
6y agoGWPHGW Pharmaceuticals receives Australian Therapeutic Goods Administration (TGA) approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsyGlobeNewswireLONDON, Sept. 23, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), a world leader in discovering, developing and delivering regulatory approved...
6y agoGWPHGW Pharmaceuticals plc (GWPH) CEO Justin Gover Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)Earnings Call Transcripts
6y agoGWPHGreenwich Biosciences to Share Results of Cannabis Use Survey Conducted with the North American Research Committee on Multiple Sclerosis (NARCOMS) at Joint ACTRIMS-ECTRIMS Meeting, MSVirtual2020GlobeNewswireCARLSBAD, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of...
6y agoGWPHGreenwich Biosciences to Present Data on Safety and Efficacy of Nabiximols in Persons with Multiple Sclerosis-Associated Spasticity at the Joint ACTRIMS-ECTRIMS Meeting, MSVirtual2020GlobeNewswire- Results from post-hoc analysis of phase 3 clinical study show nabiximols was well-tolerated and provided continued reductions in spasticity for individuals who remained on therapy - Analysis of two...
6y agoGWPHGW Pharmaceuticals Announces the Appointment of David Gryska to its Board of DirectorsGlobeNewswireLONDON, Sept. 10, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines today...
6y agoTLRY CGC ACB GWPHLegislative Breakthroughs Propel the Medical Cannabis Industry ForwardPR NewswireCannabis is continuously growing as a popular option for medical treatments due to its beneficial and diverse treatment options. In fact, multiple...
6y agoGWPHGW Pharmaceuticals to Present at Upcoming Investor ConferencesGlobeNewswireLONDON and CARLSBAD, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization...